Get the Stockscreener App
1.7657
5.58%
-0.1043
Venus Concept Inc stock is traded at $1.7657, with a volume of 130.75K.
It is down -5.58% in the last 24 hours and down -24.22% over the past month.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
See More
Previous Close:
$1.87
Open:
$1.76
24h Volume:
130.75K
Relative Volume:
0.22
Market Cap:
$3.28M
Revenue:
$82.51M
Net Income/Loss:
$-36.05M
P/E Ratio:
-0.2544
EPS:
-6.94
Net Cash Flow:
$-15.62M
1W Performance:
-11.71%
1M Performance:
-24.22%
6M Performance:
-30.21%
1Y Performance:
-52.10%
1-Day Range:
$1.68
$1.77
1-Week Range:
$1.68
$3.0199
52-Week Range:
$1.68
$14.50
Venus Concept Inc Stock (VERO) Company Profile
Name
Venus Concept Inc
Sector
Industry
Phone
877-848-8430 X117
Address
235 YORKLAND BLVD., TORONTO, ON
Compare VERO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERO
Venus Concept Inc
|
1.7657 | 3.48M | 82.51M | -36.05M | -15.62M | -6.94 |
|
ABT
Abbott Laboratories
|
128.92 | 224.00B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
104.58 | 154.37B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.99 | 140.48B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.46 | 122.89B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
85.95 | 49.66B | 5.88B | 1.34B | 799.60M | 2.3489 |
Venus Concept Inc Stock (VERO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-20 | Initiated | Stifel | Hold |
| Oct-20-20 | Initiated | Ladenburg Thalmann | Buy |
| Jul-06-20 | Initiated | BTIG Research | Buy |
| Mar-31-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-09-20 | Upgrade | Maxim Group | Hold → Buy |
View All
Venus Concept Inc Stock (VERO) Latest News
Venus Concept targets sequential Q4 growth with Venus NOVA launch amid Venus Hair sale uncertainty - MSN
Earnings call transcript: Venus Concept Q3 2025 sees revenue dip amid strategic shifts By Investing.com - Investing.com South Africa
Earnings call transcript: Venus Concept Q3 2025 sees revenue dip amid strategic shifts - Investing.com India
Venus Concept: Q3 Earnings Snapshot - San Francisco Chronicle
Venus Concept (VERO) Q3 Results Highlight New Product Launch and Financial Adjustments - GuruFocus
Venus Concept Gains FDA Clearance for Venus Nova - TipRanks
How moving averages guide Venus Concept Inc. tradingSell Signal & Safe Entry Momentum Tips - newser.com
Venus Concept Inc. SEC 10-Q Report - TradingView
Medical aesthetic device maker Venus Concept's Q3 revenue misses - MarketScreener
Venus Concept Inc. Reports Third Quarter 2025 Financial Results and Strategic Developments - Quiver Quantitative
Is Venus Concept Inc. stock positioned for long term growth2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
Ranking Venus Concept Inc. among high performing stocks via tools2025 Trading Recap & Growth Focused Entry Reports - newser.com
Venus Concept Stumbles On Sales, Bets On Device Launch - Finimize
Multi asset correlation models including Venus Concept Inc.2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
Is Venus Concept Inc. stock a buy in volatile marketsJuly 2025 Breakouts & Consistent Profit Focused Trading Strategies - newser.com
Why Venus Concept Inc. stock remains undervaluedWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Analyzing recovery setups for Venus Concept Inc. investorsJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Venus Concept receives FDA clearance for new aesthetic platform By Investing.com - Investing.com Nigeria
What indicators show strength in Venus Concept Inc.Trade Entry Summary & Entry Point Strategy Guides - newser.com
Venus Concept Gets FDA Clearance to Market Platform for Skin Treatment - MarketScreener
Venus Concept Stock: Can It Rebound to its Glory Days? - StocksToTrade
Venus Concept Inc: A Surprising Stock Surge or Just a Fling? - timothysykes.com
Venus Concept (VERO) Gains FDA Clearance for Innovative Venus NO - GuruFocus
Venus Concept receives FDA clearance for new aesthetic platform - Investing.com
Venus Concept Inc. Receives FDA Clearance for Next-Generation Venus NOVA Aesthetic Treatment Platform - Quiver Quantitative
VEROVenus Concept Inc Latest Stock News & Market Updates - Stock Titan
Can a trend reversal in Venus Concept Inc. lead to recoveryJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Should I hold or sell Venus Concept Inc. stock in 2025Portfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Will Venus Concept Inc. stock continue upward momentumTrade Exit Summary & Proven Capital Preservation Tips - newser.com
What Fibonacci levels say about Venus Concept Inc. reboundRate Cut & Community Trade Idea Sharing - newser.com
Live market analysis of Venus Concept Inc.2025 Institutional Moves & Consistent Growth Stock Picks - newser.com
Is Venus Concept Inc. stock positioned well for digital economyWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Why Venus Concept Inc. stock could outperform in 2025Weekly Profit Recap & Low Drawdown Trading Strategies - Fundação Cultural do Pará
What technical charts say about Venus Concept Inc. stock2025 Bull vs Bear & Low Drawdown Investment Ideas - fcp.pa.gov.br
Venus Concept Inc Stock (VERO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):